Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michal Kloc

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Physical Review. E|November 28, 2019
Collective performance of a finite-time quantum Otto cycleMichal Kloc, Pavel Cejnar, Gernot Schaller
Physical Review Letters|July 24, 2020
Complex Density of Continuum States in Resonant Quantum TunnelingPavel Stránský, Milan Šindelka, Michal Kloc, et al.
Journal of Mammary Gland Biology and Neoplasia|December 8, 2023
Single-cell Analysis Reveals Inter- and Intratumour Heterogeneity in Metastatic Breast CancerBaptiste Hamelin, Milan M S Obradović, Atul Sethi, et al.
EMBO Molecular Medicine|November 19, 2025
Activated glucocorticoid receptor is an estrogen receptor silencer in ER+ metastatic breast cancerMadhuri Manivannan, Charly Jehanno, Michal Kloc, et al.
Oncogene|August 25, 2022
A high-throughput drug screen reveals means to differentiate triple-negative breast cancerMilica Vulin, Charly Jehanno, Atul Sethi, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Physical Review. E|November 28, 2019
Collective performance of a finite-time quantum Otto cycleMichal Kloc, Pavel Cejnar, Gernot Schaller
Physical Review Letters|July 24, 2020
Complex Density of Continuum States in Resonant Quantum TunnelingPavel Stránský, Milan Šindelka, Michal Kloc, et al.
Journal of Mammary Gland Biology and Neoplasia|December 8, 2023
Single-cell Analysis Reveals Inter- and Intratumour Heterogeneity in Metastatic Breast CancerBaptiste Hamelin, Milan M S Obradović, Atul Sethi, et al.
EMBO Molecular Medicine|November 19, 2025
Activated glucocorticoid receptor is an estrogen receptor silencer in ER+ metastatic breast cancerMadhuri Manivannan, Charly Jehanno, Michal Kloc, et al.
Oncogene|August 25, 2022
A high-throughput drug screen reveals means to differentiate triple-negative breast cancerMilica Vulin, Charly Jehanno, Atul Sethi, et al.
Pageof 1